In addition, WNT2 and WNT1 gene expression can be considered as diagnostic or prognostic biomarkers, respectively, while Wnt-3a protein expression could be a novel HCC target in early diagnosis [67,68]. The gene discussed is WNT3A; the disease is hepatocellular carcinoma.